Active substance
Anastrozole
- SFDA 7
- US FDA 21
- Health Canada 18
- US price lines 2
- NHS prices 1
- WHO EML 2
- Safety 5
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ANADEX 1MG F.C.TABLET | 1 mg | Film-coated tablet · Oral use | 28 Blister | SAR 120.00 | Generic · Prescription | ADEL AHMED AL-SHAEIR PHARMACEUTICAL COMPANY | Valid |
| ANASTROZOLE 1MG F.C.TABLET | 1 mg | Film-coated tablet · Oral use | 28 Blister | SAR 156.75 | Generic · Prescription | LABORATORIOS CINFA SA | Valid |
| ARIMIDEX 1MG TAB | 1 mg | Film-coated tablet · Oral use | 28 Blister | SAR 184.45 | NCE · Prescription | AstraZeneca | Valid |
| Anastrozole Pharmacare | 1 mg | Film-coated tablet · Oral use | 30 Blister | SAR 128.25 | Generic · Prescription | Pharmacare Premium Ltd | Valid |
| TABIDEX 1 MG F. C. TABLET | 1 mg | Film-coated tablet · Oral use | 28 Blister | SAR 105.10 | Generic · Prescription | Accord Healthcare Limited | Valid |
| ANASTRALEX 1 MG FILM COATED TABLET | 1 mg | Tablet · Oral use | 30 Bottle | SAR 128.40 | Generic · Prescription | APOTEX INC. (SIGNET SITE) | Withdrawn by MAH · Not Marketed |
| DP-ANASTROZOLE 1 mg tablet | 1 mg | Film-coated tablet · Oral use | 30 Blister | SAR 62.55 | Generic · Prescription | DOUGLAS MANUFACTURING Ltd | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
BREAST CANCER EARLY HORMONAL; BREAST CANCER MET.HORMONAL; ENDOMETRIOSIS; OVARIAN CANCER
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ARIMIDEX | 1MG | tablet · oral | ANI PHARMS | Prescription | 27 Dec 1995 |
| ARIMIDEX | 1MG | tablet · oral | ASTRAZENECA | Prescription | 5 Dec 2008 |
| ANASTROZOLE | 1MG | tablet · oral | TEVA PHARMS | Prescription | 28 Jun 2010 |
| ANASTROZOLE | 1MG | tablet · oral | ZYDUS PHARMS USA INC | Prescription | 28 Jun 2010 |
| ANASTROZOLE | 1MG | tablet · oral | KENTON | Prescription | 28 Jun 2010 |
| ANASTROZOLE | 1MG | tablet · oral | NATCO PHARMA LTD | Prescription | 28 Jun 2010 |
| ANASTROZOLE | 1MG | tablet · oral | ACCORD HLTHCARE | Prescription | 28 Jun 2010 |
| ANASTROZOLE | 1MG | tablet · oral | CIPLA | Prescription | 28 Jun 2010 |
| ANASTROZOLE | 1MG | tablet · oral | BEIJING YILING | Prescription | 9 Nov 2018 |
| ANASTROZOLE | 1MG | tablet · oral | EUGIA PHARMA | Prescription | 24 Jul 2020 |
| ANASTROZOLE | 1MG | tablet · oral | HIKMA PHARMS | Discontinued | 28 Jun 2010 |
| ANASTROZOLE | 1MG | tablet · oral | WATSON LABS TEVA | Discontinued | 28 Jun 2010 |
| ANASTROZOLE | 1MG | tablet · oral | SANDOZ | Discontinued | 28 Jun 2010 |
| ANASTROZOLE | 1MG | tablet · oral | FRESENIUS KABI USA | Discontinued | 28 Jun 2010 |
| ANASTROZOLE | 1MG | tablet · oral | CHARTWELL RX | Discontinued | 28 Jun 2010 |
| ANASTROZOLE | 1MG | tablet · oral | PHARMOBEDIENT | Discontinued | 28 Jun 2010 |
| ANASTROZOLE | 1MG | tablet · oral | CHARTWELL MOLECULAR | Discontinued | 5 Jan 2011 |
| ANASTROZOLE | 1MG | tablet · oral | SUN PHARM INDS LTD | Discontinued | 15 Jul 2011 |
| ANASTROZOLE | 1MG | tablet · oral | APOTEX INC | Discontinued | 11 May 2012 |
| ANASTROZOLE | 1MG | tablet · oral | IMPAX LABS INC | Discontinued | 31 May 2012 |
| ANASTROZOLE | 1MG | tablet · oral | SYNTHON PHARMS | Discontinued |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ACH-ANASTROZOLE | 02351218 | 1 MG | TABLET · ORAL | ACCORD HEALTHCARE INC |
| AG-ANASTROZOLE TABLETS | 02553686 | 1 MG | TABLET · ORAL | ANGITA PHARMA INC. |
| ANASTROZOLE | 02442736 | 1 MG | TABLET · ORAL | SANIS HEALTH INC |
| ANASTROZOLE | 02529904 | 1 MG | TABLET · ORAL | SIVEM PHARMACEUTICALS ULC |
| APO-ANASTROZOLE | 02374420 | 1 MG | TABLET · ORAL | APOTEX INC |
| ARIMIDEX | 02224135 | 1 MG | TABLET · ORAL | ASTRAZENECA CANADA INC |
| BIO-ANASTROZOLE | 02392488 | 1 MG | TABLET · ORAL | BIOMED PHARMA |
| JAMP ANASTROZOLE TABLETS | 02540584 | 1 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| JAMP-ANASTROZOLE | 02339080 | 1 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| MAR-ANASTROZOLE | 02379562 | 1 MG | TABLET · ORAL | MARCAN PHARMACEUTICALS INC |
| MINT-ANASTROZOLE | 02393573 | 1 MG | TABLET · ORAL | MINT PHARMACEUTICALS INC |
| NAT-ANASTROZOLE | 02417855 | 1 MG | TABLET · ORAL | NATCO PHARMA (CANADA) INC |
| PMS-ANASTROZOLE | 02320738 | 1 MG | TABLET · ORAL | PHARMASCIENCE INC |
| PRO-ANASTROZOLE | 02395649 | 1 MG | TABLET · ORAL | PRO DOC LIMITEE |
| RIVA-ANASTROZOLE | 02392259 | 1 MG | TABLET · ORAL | LABORATOIRE RIVA INC. |
| SANDOZ ANASTROZOLE | 02338467 | 1 MG | TABLET · ORAL | SANDOZ CANADA INCORPORATED |
| TARO-ANASTROZOLE | 02365650 | 1 MG | TABLET · ORAL | TARO PHARMACEUTICALS INC |
| TEVA-ANASTROZOLE | 02394898 | 1 MG | TABLET · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | ANASTROZOLE 1 MG TABLET | $0.14163 | per EA | 23 Sep 2026 |
| US NADAC | ARIMIDEX 1 MG TABLET | $52.86163 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Anastrozole 1mg tablets | £1.06 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 8.2.4. Hormones and antihormones · complementary
Malignant neoplasms of breast; Other specified malignant neoplasms of breast
Oral > Solid: 1 mg tablet - 22.2. Ovulation inducers · complementary
Therapeutic equivalent to letrozole for Female infertility without specification whether primary or secondary
Safety signals and safety-related labeling changes
- US FDA 16 Dec 2024 ARIMIDEX — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - EMA PRAC 14 Jan 2021 PRAC signal: Depressed mood disorders
Action for MAH: update of the product information: Yes - EMA PRAC 3 Sep 2020 PRAC signal: Depressed mood disorders
Action for MAH: update of the product information: No - EMA PRAC 16 Jan 2020 PRAC signal: Hallucinations
Action for MAH: update of the product information: No - EMA PRAC 5 Sep 2019 PRAC signal: Hallucinations
Action for MAH: update of the product information: No
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.